38.43
전일 마감가:
$37.69
열려 있는:
$38.02
하루 거래량:
130.00K
Relative Volume:
0.06
시가총액:
$5.82B
수익:
$3.24B
순이익/손실:
$304.90M
주가수익비율:
18.47
EPS:
2.08
순현금흐름:
$156.70M
1주 성능:
+4.59%
1개월 성능:
-2.70%
6개월 성능:
-34.90%
1년 성능:
-40.90%
Bruker Corp Stock (BRKR) Company Profile
명칭
Bruker Corp
전화
978663-3660
주소
40 MANNING RD, BILLERICA, MA
BRKR을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
BRKR
Bruker Corp
|
38.43 | 5.65B | 3.24B | 304.90M | 156.70M | 2.08 |
![]()
ABT
Abbott Laboratories
|
134.34 | 231.14B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
102.77 | 154.60B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
387.14 | 146.12B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
87.03 | 105.64B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
77.42 | 45.60B | 5.54B | 4.18B | 623.10M | 7.00 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
2024-12-19 | 개시 | Guggenheim | Buy |
2024-12-10 | 개시 | UBS | Neutral |
2024-12-05 | 업그레이드 | Goldman | Sell → Neutral |
2024-10-15 | 개시 | Barclays | Overweight |
2024-09-30 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
2024-08-28 | 개시 | Wells Fargo | Overweight |
2024-06-03 | 재개 | Jefferies | Buy |
2024-02-14 | 업그레이드 | JP Morgan | Neutral → Overweight |
2023-12-19 | 개시 | Wells Fargo | Equal Weight |
2023-12-13 | 개시 | Wolfe Research | Outperform |
2022-10-21 | 개시 | UBS | Buy |
2022-08-22 | 업그레이드 | Citigroup | Neutral → Buy |
2021-10-15 | 재개 | Cowen | Market Perform |
2021-06-15 | 업그레이드 | Cleveland Research | Neutral → Buy |
2021-02-05 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
2020-12-02 | 개시 | Goldman | Sell |
2020-11-16 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
2020-05-01 | 다운그레이드 | Cleveland Research | Buy → Neutral |
2020-04-02 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
2020-04-01 | 다운그레이드 | Needham | Strong Buy → Hold |
2020-03-26 | 업그레이드 | Barclays | Equal Weight → Overweight |
2020-01-08 | 개시 | Wells Fargo | Overweight |
2020-01-07 | 개시 | Citigroup | Buy |
2019-11-15 | 개시 | Stifel | Hold |
2019-09-26 | 업그레이드 | BofA/Merrill | Neutral → Buy |
2019-07-15 | 업그레이드 | Goldman | Sell → Neutral |
2019-06-24 | 재확인 | Needham | Strong Buy |
2019-06-21 | 재확인 | BofA/Merrill | Neutral |
2019-05-30 | 개시 | Wolfe Research | Peer Perform |
2019-05-06 | 재확인 | Needham | Strong Buy |
2019-05-03 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
2019-05-03 | 업그레이드 | UBS | Sell → Neutral |
2019-04-12 | 업그레이드 | Deutsche Bank | Hold → Buy |
2019-02-12 | 재확인 | BTIG Research | Buy |
2019-01-03 | 개시 | Needham | Strong Buy |
모두보기
Bruker Corp 주식(BRKR)의 최신 뉴스
Bruker introduces new timsUltra AIP System at ASMS 2025 - SelectScience
Bruker at Jefferies Conference: Strategic Growth Amid Challenges - Investing.com
biocrates life sciences ag becomes part of Bruker Group - SelectScience
Bruker launches revolutionary timsOmni mass spectrometer at ASMS 2025 - SelectScience
New proteoElute nanoLC System and PepSep Advanced nLC Columns showcased at ASMS 2025 - SelectScience
Bruker Applied MS Unveils Strategic Innovations at ASMS 2025, Showcasing Advances in DART Technology for TDM and DoA Analysis and Launching timsMetabo™ for PFAS and Environmental Contaminant Detection - Quantisnow
Bruker Corporation (BRKR) Acquires Biocrates to Expand Multiomics Solutions - Insider Monkey
Bruker invests in diagnostics, unveils new analysis platform By Investing.com - Investing.com Nigeria
Should You Invest in Bruker Corp (BRKR)? - Insider Monkey
Bruker (BRKR) Acquires Biocrates to Boost Metabolomics Solutions - GuruFocus
Bruker expands multiomics with biocrates acquisition - Investing.com
Bruker (BRKR) Expands with Biocrates Life Sciences Acquisition | BRKR Stock News - GuruFocus
Bruker Announces Acquisition of biocrates, a Leader in Mass Spectrometry-based Quantitative Metabolomics - Quantisnow
Bruker unveils new mass spectrometer with enhanced sensitivity By Investing.com - Investing.com South Africa
Bruker (BRKR) Unveils Advanced Mass Spectrometer for 4D-Proteomics | BRKR Stock News - GuruFocus
Bruker (BRKR) Unveils Advanced Proteomics System at Industry Conference | BRKR Stock News - GuruFocus
Bruker Launches New timsUltra AIP System with Further Enhanced, Extreme Sensitivity for Single-Cell Proteomics, FNA Biopsy Immunopeptidomics and Metaproteomics – Company AnnouncementFT.com - Financial Times
Bruker Unveils New proteoElute™ nanoLC System and PepSep® Advanced nLC Columns for up to 50% Improved Peptide Sensitivity - Seeking Alpha
Bruker introduces novel timsMetabo mass spectrometer introduced at ASMS 2025 - SelectScience
Zacks Research Has Optimistic Outlook of Bruker Q4 Earnings - Defense World
Bruker Leadership to Share Strategic Insights at Major Jefferies Healthcare Conference Next Week - Stock Titan
Bruker (BRKR) Introduces Advanced Mass Spectrometry System | BRK - GuruFocus
Bruker launches timsOmni system for advanced proteomics - Investing.com
Revolutionary timsOmni Mass Spectrometer Transforms Protein Research and Drug Development - Stock Titan
Bruker (BRKR) Unveils Advanced 4D-Metabolomics System | BRKR Stock News - GuruFocus
Zacks Research Has Pessimistic Outlook of Bruker Q2 Earnings - Defense World
Bruker unveils new timsMetabo system for metabolomics - Investing.com
Bruker Launches Novel timsMetabo™ Mass Spectrometer for Breakthrough 4D-Metabolomics and 4D-Lipidomics Sensitivity, Specificity and Annotation Confidenceat Speed, Depth, and Scale - Yahoo Finance
Bruker Stock to Gain From the Launch of MOVE-T Liquid Dairy Analyzer - Yahoo Finance
Bruker launches MOVE-T for dairy quality control By Investing.com - Investing.com South Africa
Bruker Corp: Pan-Omics Dominance At A Margin Inflection Point (BRKR) - Seeking Alpha
Bruker launches MOVE-T for dairy quality control - Investing.com
Bruker Introduces Novel MOVE-T System for Transferable, Robust Milk and Liquid Dairy Analysis with FT-NIR Technology - Quantisnow
Bruker Corp (BRKR) Shares Up 4.51% on May 27 - GuruFocus
Deutsche Bank AG Has $865,000 Position in Bruker Co. (NASDAQ:BRKR) - Defense World
Bruker (BRKR) Downgraded by Citigroup with Price Target Lowered to $40 | BRKR Stock News - GuruFocus
Expert Outlook: Bruker Through The Eyes Of 8 Analysts - Benzinga
This Guidewire Software Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Benzinga
Citi cuts Bruker stock rating, lowers price target to $40 - Investing.com
Bruker (BRKR) Downgraded to Neutral by Citi with $40 Price Target | BRKR Stock News - GuruFocus
Bruker Corp (BRKR) Shares Down 3.3% on May 21 - GuruFocus
Benchtop Optofluidic System | Bruker Nano Surfaces | Products - Photonics Spectra
Bruker (BRKR) Shows Positive Signals Post-Settlement | BRKR Stock News - GuruFocus
Bruker (BRKR) Shows Positive Signals Post-Settlement | BRKR Stoc - GuruFocus
July 18th Options Now Available For Bruker (BRKR) - Nasdaq
Bruker (BRKR) and 10x Genomics Resolve Global Patent Dispute | B - GuruFocus
Bruker (BRKR) and 10x Genomics Settle Patent Disputes Globally - GuruFocus
Bruker Sets Next Dividend Payment: $0.05 Per Share Coming June 27Key Dates Inside - Stock Titan
10x Genomics settles patent dispute with Bruker for $68 million By Investing.com - Investing.com Canada
10x Genomics settles patent dispute with Bruker for $68 million - Investing.com
10x Genomics Announces Patent Litigation Settlement Agreement with Bruker - Financial Times
Bruker Corp (BRKR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Bruker Corp 주식 (BRKR) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
LINTON WILLIAM A | Director |
Apr 22 '25 |
Option Exercise |
24.00 |
10,000 |
240,000 |
58,723 |
Bures Thomas | Chief Accounting Officer |
Mar 10 '25 |
Buy |
47.40 |
500 |
23,698 |
3,472 |
LAUKIEN FRANK H | PRESIDENT & CEO |
Feb 18 '25 |
Buy |
50.92 |
20,000 |
1,018,330 |
38,459,563 |
PACKER RICHARD A | Director |
Dec 02 '24 |
Option Exercise |
19.12 |
10,000 |
191,200 |
84,254 |
PACKER RICHARD A | Director |
Dec 02 '24 |
Sale |
57.82 |
3,350 |
193,683 |
80,904 |
자본화:
|
볼륨(24시간):